Efficacy of early stereotactic body radiotherapy to the primary lung lesion in patients with NSCLC harboring sensitive EGFR mutations treated with first-line EGFR-TKIs

被引：0
|
作者：
Tao, D. [1 ]
Lei, H. [2 ]
Tan, J. [1 ]
Yang, D. [1 ]
Jiang, Y. [1 ]
Zhou, W. [1 ]
Wang, Y. [1 ]
Wu, Y. [1 ]
机构：
[1] Chongqing Univ, Dept Radiat Oncol, Canc Hosp, Chongqing, Peoples R China
[2] Chongqing Univ, Chongqing Canc Multi Omics Big Data Applicat Engn, Canc Hosp, Chongqing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2384
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1351P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Urinary circulating DNA detection for dynamic tracking of EGFR mutations for NSCLC patients treated with EGFR-TKIs
    S. Chen
    J. Zhao
    L. Cui
    Y. Liu
    Clinical and Translational Oncology, 2017, 19 : 332 - 340
  • [32] Urinary circulating DNA detection for dynamic tracking of EGFR mutations for NSCLC patients treated with EGFR-TKIs
    Chen, S.
    Zhao, J.
    Cui, L.
    Liu, Y.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (03): : 332 - 340
  • [33] Association between clinical outcome of first EGFR-TKIs and T790M mutation in NSCLC patients harboring EGFR mutation with acquired resistance to EGFR-TKIs
    Oya, Y.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S622 - S622
  • [34] Radiation-induced lung damage in patients treated with stereotactic body radiotherapy after EGFR-TKIs: is there any difference from stereotactic body radiotherapy alone?
    Tang, Xingni
    Shen, Yichao
    Meng, Yinnan
    Hou, Liqiao
    Zhou, Chao
    Yu, Changhui
    Jia, Haijian
    Wang, Wei
    Ren, Ge
    Cai, Jing
    Li, X. Allen
    Yang, Haihua
    Kong, Feng-Ming
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (03) : 2832 - 2842
  • [35] Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study
    An, Ning
    Wang, Haoyi
    Li, Ji
    Zhai, Xiaoyang
    Jing, Wang
    Jia, Wenxiao
    Kong, Li
    Zhu, Hui
    Yu, Jinming
    ONCOTARGETS AND THERAPY, 2019, 12 : 8311 - 8318
  • [36] Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations
    Guowei ZHANG
    Ruirui CHENG
    Yuanyuan NIU
    Huijuan WANG
    Xiangtao YAN
    Mina ZHANG
    Xiaojuan ZHANG
    Jinpo YANG
    Chunhua WEI
    Zhiyong MA
    中国肺癌杂志, 2022, (09) : 651 - 657
  • [37] Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutations
    Holleman, Marscha S.
    Al, Maiwenn J.
    Zaim, Remziye
    Groen, Harry J. M.
    Uyl-de Groot, Carin A.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2020, 21 (01): : 153 - 164
  • [38] Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutations
    Marscha S. Holleman
    Maiwenn J. Al
    Remziye Zaim
    Harry J. M. Groen
    Carin A. Uyl-de Groot
    The European Journal of Health Economics, 2020, 21 : 153 - 164
  • [39] Local Ablative Therapy Improves Survival in Patients with Synchronous Oligometastatic NSCLC Harboring EGFR Mutation Treated with EGFR-TKIs
    Xu, Q.
    Zhou, F.
    Liu, H.
    Xu, Y.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S337 - S337
  • [40] Clinical efficacy of EGFR-TKIs in combination with chemotherapy in patients with advanced non-small cell lung cancer harboring EGFR mutations
    Zhang, Minghui
    Liu, Mingyang
    Wang, Yan
    JOURNAL OF THORACIC DISEASE, 2016, 8 (10) : E1293 - E1295
12345